A Toddler’s High Cholesterol Journey: Unraveling a Diagnosis Puzzle in the Absence of Family History

In this case, a 5-year-old female with significantly elevated low-density lipoprotein cholesterol (LDL-C) levels was initially misdiagnosed with familial hypercholesterolemia (FH). However, genetic testing ruled out FH, prompting further investigation. The diagnosis shifted to lysosomal acid lipase deficiency (LAL-D), a rare autosomal recessive disorder caused by LIPA gene mutations. Treatment with sebelipase-alfa and ezetimibe resulted in notable improvements in aminotransferase levels and LDL-C reduction. This case emphasizes the importance of considering alternative lipid disorders when patients exhibit atypical responses to standard therapies, highlighting the need for increased awareness of rare conditions like LAL-D to ensure accurate diagnosis and timely intervention.

Authors

Institutions

Publication Details

Journal
Journal of Atherosclerosis Prevention and Treatment
Published
2025-04-01
DOI
https://doi.org/10.4103/aptj.aptj_13_25
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Toddler’s High Cholesterol Journey: Unraveling a Diagnosis Puzzle in the Absence of Family History

Eleftheria M. Mastoridou, Antonios P. Vlahos, Haralampos Milionis, Aikaterini Zioga
Journal of Atherosclerosis Prevention and Treatment
Lysosomal Storage Disorders Research
article

A Toddler’s High Cholesterol Journey: Unraveling a Diagnosis Puzzle in the Absence of Family History

Eleftheria M. Mastoridou, Antonios P. Vlahos, Haralampos Milionis, Aikaterini Zioga
article en

Abstract

In this case, a 5-year-old female with significantly elevated low-density lipoprotein cholesterol (LDL-C) levels was initially misdiagnosed with familial hypercholesterolemia (FH). However, genetic testing ruled out FH, prompting further investigation. The diagnosis shifted to lysosomal acid lipase deficiency (LAL-D), a rare autosomal recessive disorder caused by LIPA gene mutations. Treatment with sebelipase-alfa and ezetimibe resulted in notable improvements in aminotransferase levels and LDL-C reduction. This case emphasizes the importance of considering alternative lipid disorders when patients exhibit atypical responses to standard therapies, highlighting the need for increased awareness of rare conditions like LAL-D to ensure accurate diagnosis and timely intervention.

Journal of Atherosclerosis Prevention and TreatmentVol. 16(2)
University Hospital of Ioannina (GR)
Gender equality
Openalex Percentile: Top 27%
Lysosomal Storage Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.